SEHK:2696Biotechs
What Recent Partnership News Means for Shanghai Henlius Biotech’s Valuation in 2025
Deciding what to do with Shanghai Henlius Biotech stock these days? You are definitely not alone. The stock has been making waves and, depending on your lens, could be at an intriguing crossroads. If you are watching its recent movements, you might have caught last week’s dip of -11.8%. At first glance, that could spook even seasoned investors. But zoom out and you will notice a much bigger picture: despite the short-term stumble, Henlius has delivered an eye-popping 212.6% gain year to date...